| Name | Title | Contact Details |
|---|
Assessment Technologies Institute is a Stilwell, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
WellGen is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in N Brunswick, NJ. To find more information about WellGen, please visit www.amphioncap.com
Alego Health is a Eastlake, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NeoMend is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.